Melatonin for nondippers with coronary artery disease: Assessment of blood pressure profile and heart rate variability

Hypertension Research

Volumn 33, Issue 1, 2010, Pages 56-61

  Rechciński, Tomasz ^a   Trzos, Ewa ^a   Wierzbowska Drabik, Karina ^a   Krzemińska Pakuła, Maria ^a   Kurpesa, Małgorzata ^a  

^a Medical University of Lodz Bieganski Hospital   (Poland)

Author keywords

Blood pressure; Coronary artery disease; Melatonin; Nondipping

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MELATONIN; NITRATE; ORAL ANTIDIABETIC AGENT; PLACEBO; SIBUTRAMINE; TRIMETAZIDINE;

ADULT; AGED; ARTICLE; BEDTIME DOSAGE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CIRCADIAN RHYTHM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; MALE; MELATONIN; MIDDLE AGED; RISK FACTORS;

EID: 74349111287     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.174     Document Type: Article

References (23)

1. Benfoucif S, Guico MJ, Reid KJ, Wolfe LE, L'hermite-Baleriaux M, Zee PC. Stability of melatonin and temperature as circadian phase markers and their relation to sleep time in humans. J Biol Rhythms 2005; 20: 178-181.
2. Sakotnik A, Liebmann PM, Stoschitzky K, Lercher P, Schauenstein K, Klein W, Eber W. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 1999; 20: 1314-1317.
3. Brugger P, Marktl W, Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995; 345: 1408.
4. Girotti L, Lago M, Ianowsky O, Carbajales J, Elizari MV, Brusco LI, Cardinali DP. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery diseases. J Pineal Res 2000; 29: 138-142.
5. Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press 2003; 12: 19-24.
6. Zeman M, Dulkova K, Bada V, Herichova I. Plasma melatonin concentrations in hypertensive patients with the dipping and nondipping blood pressure profile. Life Sci 2005; 76: 1795-1803.
7. Kurpesa M, Trzos E, Drozdz J, Bednarkiewicz Z, Krzemińska-Pakua M. Myocardial ischemia and autonomic activity in dippers and non-dippers with coronary artery disease: assessment of normotensive and hypertensive patients. Int J Cardiol 2002; 83: 133-142.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Rocella EJ. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-2572. (Pubitemid 37430158)
9. Asmar R, Bemetos A, Topouchian, Laurent P, Pannier B, Brisac AM, Target R, Levy BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485-490.
10. Cowen PJ, Bevan JS, Gosden B, Elliot SA. Treatment with beta-adrenoreceptors blockers reduces plasma melatonin concentrations. Br J Clin Pharmacol 1985; 19: 258-260.
11. Lusardi P, Piazza E, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-h study. Br J Clin Pharmacol 2000; 49: 423-427.
12. Lurbe E, Redon J, Pascual JM, Tacons J, Alvarez V. The spectrum of circadian blood pressure changes in type I diabetic patients. J Hypertens 2001; 19: 1421-1428.
13. Stella P, Tabak AG, Zgibor JC, Orchard TJ. Late diabetes complications and non-dipping phenomenon in patients with type 1 diabetes. Diabetes Res Clin Pract 2006; 71: 14-20.
14. Guasti L, Simoni C, Mainardi LT, Cimpanelli M, Crespi C, Gaudio G, Clersy C, Grandi AM, Cerruti S, Venco A. Circadian blood pressure variability is associated with autonomic and baroreflex-mediated modulation of sinoatrial node. Acta Cardiol 2005; 60: 319-324.
15. Ragot S, Herpin D, Siche JP, Ingrand P, Mallion JM. Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients. What about sex differences? J Hypertens 1999; 17: 1805-1811. (Pubitemid 30345314)
16. Lekakis JP, Zakopoulos NA, Protogerou AD, Papaioannou TG, Kotsis VT, Pitiriga VCh, Tsitsirikos MD, Stamatelopoulos KS, Papamichael CM, Mavrikakis ME. Arterial stiffness assessed by pulse wave analysis in essential hypertension: relation to 24-h blood pressure profile. Int J Cardiol 2005; 102: 391-395.
17. Pierdomenico SD, Bucci A, Constantini F, Lappena D, Cuccurillo F, Mezzetti A. Circadian blood pressure changes and myocardial ischemia in hypertensive patients with coronary artery disease. JACC 1998; 31: 1627-1634.
18. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline. The Ohasama Study. Hypertension 2006; 24: 1841-1848.
19. Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S. Association between nocturnal blood pressure reduction and a progression of visual field defect in patients with primary open-angle or normal-tension glaucoma. Jpn J Ophtalmol 2004; 48: 380.
20. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada R. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-135.
21. Zakopoulos NA, Vemmos KN, Kotsis VTh, Pitiriga VCh, Stamatelopoulos SF, Moulo-poulos SD. Reproducibility of ambulatory blood pressure measurements in essential hypertension. Blood Press Monit 2001; 6: 42-45.
22. K-Laflamme A, Wu L, Foucart S, de Champlain J. Impaired basal sympathetic tone and alfa1-adrenergic responsiveness in association with the hypotensive effect in spontaneously hypertensive rats. Am J Hypertens 1998; 11: 219-229.
23. Rechciński T, Kurpesa M, Trzos E, Krzemińska-Pakua M. The influence of mela-tonin supplementation on circadian pattern of blood pressure in patients with coronary artery disease-preliminary report. Pol Arch Med Wewn 2006; 115: 520-528.